Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone. J Neurooncol. 2017 Dec; 135(3):581-591.
View in:
PubMed
subject areas
Adolescent
Adolescent
Adult
Adult
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
Bevacizumab
Bevacizumab
Brain Neoplasms
Brain Neoplasms
Disease Progression
Disease Progression
Female
Female
Follow-Up Studies
Follow-Up Studies
Glioma
Glioma
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Neoplasm Grading
Neoplasm Grading
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Propensity Score
Propensity Score
Proportional Hazards Models
Proportional Hazards Models
Re-Irradiation
Re-Irradiation
Salvage Therapy
Salvage Therapy
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
Young Adult
Young Adult
authors with profiles
Ian F Dunn